According to the recent Center for Disease Control (CDC) report, more than half of suicide decedents between 2000 and 2016 were never diagnosed with a mental health condition, and only a quarter disclosed suicide intent prior to ending their lives. These striking findings challenge the practice of using suicidal ideation as a cornerstone of suicide risk assessment, and may partially account for our failure to contain the increase in US suicide deaths. The CDC report also underscores the urgent need for innovative suicide risk assessment methods that do not rely on a history of mental illness or self-reported suicidal ideation/intent.
This webinar aims to acquaint clinicians with a novel framework for the assessment of short-term suicide risk: the Modular Assessment of Risk for Imminent Suicide (MARIS) and the Narrative-Crisis Model of suicidal behavior (NCM). The effectiveness of the MARIS-NCM approach is described in multiple peer-reviewed publications, and in the book The Suicidal Crisis by Galynker (2017; Oxford University Press), a recommended resource by the American Foundation for Suicide Prevention.
The webinar initially presents an overview of the research findings supporting the NCM model, the new clinical entity of the Suicide Crisis Syndrome (SCS) and the MARIS method for the assessment of imminent suicidal risk. The webinar concludes by describing the use of clinicians’ emotional responses as tools for assessment and management of imminent suicidal behavior as well as clinicians’ psychological defense mechanisms elicited by suicidal patients following by practical training in emotional self-awareness.
1. Learn the nuts and bolts of MARIS- and NCM-based approach to the assessment of imminent risk
2. Apply the MARIS- and NCM-based approach to assess imminent suicide risk in test cases.
3. Learn and understand clinicians emotional responses to suicidal patients which indicate imminent suicide risk.
Dr. Igor Galynker is the Director of Research and the Director of Suicide Research and Prevention Laboratory in the Department of Psychiatry at Mount Sinai Beth Israel. He is a Professor of Psychiatry at the Icahn School of Medicine in New York City and the Founder and Director of the Richard and Cynthia Zirinsky Center for Bipolar Disorder. His research interests lie in diagnosis and treatment of acute pre-suicidal mental state, the Suicide Crisis Syndrome as well as the development and implementation of the Modular Assessment of Risk for Imminent Suicide (MARIS). More recently Galynker has been working on creating scalable web-based methods to train clinicians in emotional self-awareness and empathic communication when working with suicidal patients. He has published extensively on these topics in professional journals and in the lay press, and has authored a book “The Suicidal Crisis” published by the Oxford University Press.
Igor Galynker received his PhD in Chemistry from Columbia University in 1982 where he received a Hammett Award for Outstanding Research. He received his medical degree in 1988 from the Albert Einstein College of Medicine, where he was elected into the Alpha Omega Alpha Honor Medical Society. Galynker completed his psychiatry residency at Mount Sinai Medical Center. He has since worked at Mount Sinai Beth Israel in Manhattan.